Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia
- PMID: 1350197
Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia
Abstract
Dopamine appears to be of less importance in the regulation of psychomotor functions than was previously thought. A central dopaminergic-glutamatergic balance may be important for both akinetic motor disorders and psychosis. In Parkinson's disease glutamate antagonists may counteract central glutamatergic hyperactivity and may be of value as anti-parkinsonian drugs. An increase of dopaminergic activity and/or a reduction of glutamatergic activity may contribute to the development of paranoid hallucinatory psychosis in schizophrenic patients and of pharmacotoxic psychosis in Parkinson's disease. Because of possibly severe side-effects of glutamatergic antagonists and agonists in the treatment of akinesia and psychosis, the development of partial glutamate agonists/antagonists could be an alternative strategy capable of producing antipsychotic or anti-kinetic effects with only mild adverse reaction.
Similar articles
-
Glutamate receptor antagonism: neurotoxicity, anti-akinetic effects, and psychosis.J Neural Transm Suppl. 1991;34:203-10. doi: 10.1007/978-3-7091-9175-0_26. J Neural Transm Suppl. 1991. PMID: 1687783 Review.
-
[A biochemical theory of schizophrenia].Nervenarzt. 1984 Nov;55(11):602-6. Nervenarzt. 1984. PMID: 6151120 German.
-
Role of dopamine in schizophrenia and Parkinson's disease.Br J Nurs. 1998 Jul 23-Aug 12;7(14):832-4, 836, 838-41. doi: 10.12968/bjon.1998.7.14.5636. Br J Nurs. 1998. PMID: 9849144 Review.
-
Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders.Drug News Perspect. 2005 Nov;18(9):561-6. doi: 10.1358/dnp.2005.18.9.953668. Drug News Perspect. 2005. PMID: 16421629 Review.
-
Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.J Neurosci Res. 1996 Jan 1;43(1):55-62. doi: 10.1002/jnr.490430107. J Neurosci Res. 1996. PMID: 8838574
Cited by
-
Acetylcholine becomes the major excitatory neurotransmitter in the hypothalamus in vitro in the absence of glutamate excitation.J Neurosci. 2001 Mar 15;21(6):2015-27. doi: 10.1523/JNEUROSCI.21-06-02015.2001. J Neurosci. 2001. PMID: 11245685 Free PMC article.
-
N-methyl-D-aspartate (NMDA) antagonists in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):427. doi: 10.1136/jnnp.56.4.427. J Neurol Neurosurg Psychiatry. 1993. PMID: 8097763 Free PMC article. No abstract available.
-
CHRM2 and GRIN2A polymorphisms in tardive dyskinesia and cognitive impairments in Chinese Han schizophrenia.J Neural Transm (Vienna). 2025 May 30. doi: 10.1007/s00702-025-02954-8. Online ahead of print. J Neural Transm (Vienna). 2025. PMID: 40445323
-
Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice.J Neural Transm Gen Sect. 1994;97(3):197-209. doi: 10.1007/BF02336141. J Neural Transm Gen Sect. 1994. PMID: 7873129
-
Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.Neurochem Int. 2009 Jan;54(1):56-64. doi: 10.1016/j.neuint.2008.10.007. Epub 2008 Nov 1. Neurochem Int. 2009. PMID: 19010365 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical